InvestorsObserver
×
News Home

Should Medical Devices Stock Neurometrix Inc (NURO) Be in Your Portfolio Monday?

Monday, October 17, 2022 01:29 PM | InvestorsObserver Analysts

Mentioned in this article

Should Medical Devices Stock Neurometrix Inc (NURO) Be in Your Portfolio Monday?

A rating of 4 puts Neurometrix Inc (NURO) near the bottom of the Medical Devices industry according to InvestorsObserver. Neurometrix Inc's score of 4 means it scores higher than 4% of stocks in the industry. Neurometrix Inc also received an overall rating of 13, putting it above 13% of all stocks. Medical Devices is ranked 55 out of the 148 industries.

Overall Score - 13
NURO has an Overall Score of 13. Find out what this means to you and get the rest of the rankings on NURO!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Neurometrix Inc Stock Today?

Neurometrix Inc (NURO) stock is trading at $2.04 as of 1:21 PM on Monday, Oct 17, a gain of $0.06, or 2.94% from the previous closing price of $1.98. The stock has traded between $1.95 and $2.05 so far today. Volume today is light. So far 49,704 shares have traded compared to average volume of 662,482 shares. Click Here to get the full Stock Report for Neurometrix Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App